Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan

Fu-Hsiung Su, Fang Yeh Chu, Chyi-Huey Bai, Yu-Shiang Lin, Yu-Mei Hsueh, Fung Chang Sung, Chih-Ching Yeh

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background & Aims Long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. We evaluated the efficacy of a modified 3-dose booster protocol in neonatally vaccinated university students in Taiwan. Methods Changes in the levels of antibodies to the hepatitis B surface antigen (anti-HBs) were examined in 250 university students over a 3-year period. Group A (n = 39) lacked seroprotective levels of anti-HBs, and declined to receive a booster dose of the HBV vaccine. Group B (n = 128) lacked seroprotective levels of anti-HBs, and received booster doses of the HBV vaccine according to a modified 3-dose booster protocol. Group C (n = 83) possessed seroprotective levels of anti-HBs, and did not receive a booster dose. Results The levels of seroprotective anti-HBs increased in 12.8% of Group A and 14.5% of Group C, suggesting that our entire cohort had experienced booster effects from natural HBV exposure. However, no new HBV infections were observed, and 53.9% of Group B maintained protective levels of anti-HBs during the follow-up period. Conclusions The use of the modified 3-dose booster protocol induced significant long-term increases in the titer of anti-HBs in over 50% of the neonatally vaccinated participants with previously non-protective titers. However, in the absence of a vaccine booster, some neonatally vaccinated people with low anti-HBs titers may nonetheless produce anamnestic responses to HBV upon exposure, suggesting that protection from neonatal vaccination may persist, despite low titers of anti-HBs.

Original languageEnglish
Pages (from-to)684-689
Number of pages6
JournalJournal of Hepatology
Volume58
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Hepatitis B Vaccines
Taiwan
Hepatitis B virus
Vaccination
Students
Virus Diseases
Hepatitis B Surface Antigens
Vaccines
Antibodies

Keywords

  • Antibody
  • Follow-up
  • Hepatitis B
  • Protective immunity
  • Vaccination

ASJC Scopus subject areas

  • Hepatology

Cite this

Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan. / Su, Fu-Hsiung; Chu, Fang Yeh; Bai, Chyi-Huey; Lin, Yu-Shiang; Hsueh, Yu-Mei; Sung, Fung Chang; Yeh, Chih-Ching.

In: Journal of Hepatology, Vol. 58, No. 4, 04.2013, p. 684-689.

Research output: Contribution to journalArticle

@article{943d94a2e493407e81bbd80079a813d7,
title = "Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan",
abstract = "Background & Aims Long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. We evaluated the efficacy of a modified 3-dose booster protocol in neonatally vaccinated university students in Taiwan. Methods Changes in the levels of antibodies to the hepatitis B surface antigen (anti-HBs) were examined in 250 university students over a 3-year period. Group A (n = 39) lacked seroprotective levels of anti-HBs, and declined to receive a booster dose of the HBV vaccine. Group B (n = 128) lacked seroprotective levels of anti-HBs, and received booster doses of the HBV vaccine according to a modified 3-dose booster protocol. Group C (n = 83) possessed seroprotective levels of anti-HBs, and did not receive a booster dose. Results The levels of seroprotective anti-HBs increased in 12.8{\%} of Group A and 14.5{\%} of Group C, suggesting that our entire cohort had experienced booster effects from natural HBV exposure. However, no new HBV infections were observed, and 53.9{\%} of Group B maintained protective levels of anti-HBs during the follow-up period. Conclusions The use of the modified 3-dose booster protocol induced significant long-term increases in the titer of anti-HBs in over 50{\%} of the neonatally vaccinated participants with previously non-protective titers. However, in the absence of a vaccine booster, some neonatally vaccinated people with low anti-HBs titers may nonetheless produce anamnestic responses to HBV upon exposure, suggesting that protection from neonatal vaccination may persist, despite low titers of anti-HBs.",
keywords = "Antibody, Follow-up, Hepatitis B, Protective immunity, Vaccination",
author = "Fu-Hsiung Su and Chu, {Fang Yeh} and Chyi-Huey Bai and Yu-Shiang Lin and Yu-Mei Hsueh and Sung, {Fung Chang} and Chih-Ching Yeh",
year = "2013",
month = "4",
doi = "10.1016/j.jhep.2012.11.036",
language = "English",
volume = "58",
pages = "684--689",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan

AU - Su, Fu-Hsiung

AU - Chu, Fang Yeh

AU - Bai, Chyi-Huey

AU - Lin, Yu-Shiang

AU - Hsueh, Yu-Mei

AU - Sung, Fung Chang

AU - Yeh, Chih-Ching

PY - 2013/4

Y1 - 2013/4

N2 - Background & Aims Long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. We evaluated the efficacy of a modified 3-dose booster protocol in neonatally vaccinated university students in Taiwan. Methods Changes in the levels of antibodies to the hepatitis B surface antigen (anti-HBs) were examined in 250 university students over a 3-year period. Group A (n = 39) lacked seroprotective levels of anti-HBs, and declined to receive a booster dose of the HBV vaccine. Group B (n = 128) lacked seroprotective levels of anti-HBs, and received booster doses of the HBV vaccine according to a modified 3-dose booster protocol. Group C (n = 83) possessed seroprotective levels of anti-HBs, and did not receive a booster dose. Results The levels of seroprotective anti-HBs increased in 12.8% of Group A and 14.5% of Group C, suggesting that our entire cohort had experienced booster effects from natural HBV exposure. However, no new HBV infections were observed, and 53.9% of Group B maintained protective levels of anti-HBs during the follow-up period. Conclusions The use of the modified 3-dose booster protocol induced significant long-term increases in the titer of anti-HBs in over 50% of the neonatally vaccinated participants with previously non-protective titers. However, in the absence of a vaccine booster, some neonatally vaccinated people with low anti-HBs titers may nonetheless produce anamnestic responses to HBV upon exposure, suggesting that protection from neonatal vaccination may persist, despite low titers of anti-HBs.

AB - Background & Aims Long-term protection against hepatitis B virus (HBV) after vaccination remains widely debated. We evaluated the efficacy of a modified 3-dose booster protocol in neonatally vaccinated university students in Taiwan. Methods Changes in the levels of antibodies to the hepatitis B surface antigen (anti-HBs) were examined in 250 university students over a 3-year period. Group A (n = 39) lacked seroprotective levels of anti-HBs, and declined to receive a booster dose of the HBV vaccine. Group B (n = 128) lacked seroprotective levels of anti-HBs, and received booster doses of the HBV vaccine according to a modified 3-dose booster protocol. Group C (n = 83) possessed seroprotective levels of anti-HBs, and did not receive a booster dose. Results The levels of seroprotective anti-HBs increased in 12.8% of Group A and 14.5% of Group C, suggesting that our entire cohort had experienced booster effects from natural HBV exposure. However, no new HBV infections were observed, and 53.9% of Group B maintained protective levels of anti-HBs during the follow-up period. Conclusions The use of the modified 3-dose booster protocol induced significant long-term increases in the titer of anti-HBs in over 50% of the neonatally vaccinated participants with previously non-protective titers. However, in the absence of a vaccine booster, some neonatally vaccinated people with low anti-HBs titers may nonetheless produce anamnestic responses to HBV upon exposure, suggesting that protection from neonatal vaccination may persist, despite low titers of anti-HBs.

KW - Antibody

KW - Follow-up

KW - Hepatitis B

KW - Protective immunity

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84880936773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880936773&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2012.11.036

DO - 10.1016/j.jhep.2012.11.036

M3 - Article

VL - 58

SP - 684

EP - 689

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - 4

ER -